NAFDAC Warns of Counterfeit Combiart Tablets Sold in Nigeria: Public Alert Issued

NAFDAC Alerts Public on Counterfeit Combiart Tablets

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a warning about counterfeit Combiart (Artemether Lumefantrine 20/120mg) Dispersible Tablets being sold in Nigeria.

The public alert, marked No. 043/2024, appears on the NAFDAC website. The counterfeit drugs were manufactured between February and June 2023. Their expiration dates are May and June 2026, with Batch Number 7225119 and NAFDAC Registration Number A11-0299.

The genuine product is made by Strides Arcolab Limited, located at 36/7, Suragajakkanahalli, Indlavadi Cross, Anekal Taluk, Bangalore-562 106, India.

NAFDAC has instructed its zonal directors and state coordinators to monitor and remove these counterfeit products from circulation. The agency urges importers, distributors, retailers, healthcare professionals, and caregivers to be cautious and avoid handling these counterfeit items.

All medical products should be sourced from authorized suppliers. Users must verify the authenticity and condition of the products they receive.

Healthcare professionals and consumers should report any suspected sale of fake or low-quality medicines or medical devices to the nearest NAFDAC office. They can contact NAFDAC at 0800-162-3322 or report via email at [protected email].

Additionally, users are encouraged to report adverse effects using the Med-safety application, available on Android and iOS, or through email at [protected email].

NAFDAC will share this alert with the WHO Global Surveillance and Monitoring System (GSMS).